Financhill
Back

Vertex Pharmaceuticals Quote, Financials, Valuation and Earnings

New AI Stock Payouts

Watch this presentation before then!
Buy
60

VRTX
Vertex Pharmaceuticals

Last Price:
355.00
Seasonality Move:
-1.51%

7 Day Trial

ALL ACCESS PASS

$ 7

R.I.P. for the American Dream? (Surprising answer inside...)

Go here now for the details.

Vertex Pharmaceuticals Price Quote

$355.00
+2.69 (+0.76%)
(Updated: September 21, 2023 at 3:00 PM ET)

Vertex Pharmaceuticals Key Stats

Buy
60
Vertex Pharmaceuticals (VRTX) is a Buy

Day range:
$352.18 - $358.59
52-week range:
$276.57 - $367.00
Dividend yield:
0%
P/E ratio:
27.48
P/S ratio:
9.64
P/B ratio:
5.88%

Volume:
903.4K
Avg. volume:
818.7K
1-year change:
22.78%
Market cap:
$90.9B
Revenue:
$8.9B
EPS:
$12.95

How Much Does Vertex Pharmaceuticals Make?

Is Vertex Pharmaceuticals Growing As A Company?

Vertex Pharmaceuticals Stock Price Performance

What Is Vertex Pharmaceuticals 52-Week High & Low?

Vertex Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Vertex Pharmaceuticals?

Is Vertex Pharmaceuticals Cash Flow Positive?

  • What Is VRTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.1B
  • What Is Vertex Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$297.4M
  • What Is Vertex Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.3B

Vertex Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRTX return on invested capital is 24.46%
  • What Is Vertex Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 18.74%
  • What Is VRTX Return On Equity?
    ROE is a measure of profitability and is 24.46%

Vertex Pharmaceuticals Earnings Date & Stock Price

Vertex Pharmaceuticals Competitors

Vertex Pharmaceuticals Dividend Yield

Data Unavailable

Vertex Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 12.46% 0.15%
Revenue: 13.52% 3%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 11
Sell Recommendations: 0
Price Target: 384.26
Upside from Last Price: 9.07%

Major Shareholders

  • How many VRTX shares are owned by institutional investors?
    417.3M VRTX shares are owned by institutional investors
  • How many VRTX shares are owned by insiders?
    2.5M VRTX shares are owned by insiders